Joint Committee on Statutory Instruments Nineteenth Report


Instruments reported


The Committee has considered the following instrument, and has determined that the special attention of both Houses should be drawn to it on the ground specified.

1 Medicines for Human Use (Clinical Trials) Regulations 2004: defective drafting


Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031)


1.1 The Committee draws the special attention of both Houses to these Regulations on the ground that they are defectively drafted.

1.2 In a memorandum printed at the Appendix, the Department of Health acknowledges that the references in the various provisions mentioned in the Committee's question should have been as indicated by the Committee. It also accepts that paragraph 1(1) of Schedule 4 should have been expressed to apply to the case where the Authority receives a notice pursuant to regulation 16(4)(b), and undertakes to correct the errors at the earliest opportunity. The Committee accordingly reports the provisions in question for defective drafting, acknowledged by the Department.


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2004
Prepared 21 May 2004